96
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Patient satisfaction after switching from warfarin to apixaban in patients with nonvalvular atrial fibrillation: AGAIN study

, , , , , , & show all
Pages 1987-1996 | Published online: 15 Dec 2017

References

  • BenjaminEJLevyDVaziriSMD’AgostinoRBBelangerAJWolfPAIndependent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart StudyJAMA1994271118408448114238
  • KokuboYWatanabeMHigashiyamaANakaoYMKusanoKMiyamotoYDevelopment of a basic risk score for incident atrial fibrillation in a Japanese general population – the Suita StudyCirc J201781111580158828539563
  • WangTJPariseHLevyDObesity and the risk of new-onset atrial fibrillationJAMA2004292202471247715562125
  • MorinDPBernardMLMadiasCRogersPAThihalolipavanSEstesNA3rdThe state of the art: atrial fibrillation epidemiology, prevention, and treatmentMayo Clin Proc201691121778181027825618
  • ColillaSCrowAPetkunWSingerDESimonTLiuXEstimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult populationAm J Cardiol201311281142114723831166
  • GoASHylekEMPhillipsKAPrevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) StudyJAMA2001285182370237511343485
  • DantasGCThompsonBVMansonJATracyCSUpshurREPatients’ perspectives on taking warfarin: qualitative study in family practiceBMC Fam Pract200451515268764
  • SiltariAVapaataloHVascular calcification, vitamin K and warfarin therapy – possible or plausible connection?Basic Clin Pharmacol Toxicol Epub2017621
  • MozosIStoianDLucaCTCrosstalk between vitamins A, B12, D, K, C, and E status and arterial stiffnessDis Markers20172017878497128167849
  • YamamotoKKoretsuneYAkasakaTEffects of vitamin K antagonist on aortic valve degeneration in non-valvular atrial fibrillation patients: prospective 4-year observational studyThromb Res2017160697529121522
  • GrangerCBAlexanderJHMcMurrayJJApixaban versus warfarin in patients with atrial fibrillationN Engl J Med20113651198199221870978
  • JanuaryCTWannLSAlpertJS2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm SocietyCirculation2014130232071210424682348
  • BarbosaCDBalpMMKulichKGermainNRofailDA literature review to explore the link between treatment satisfaction and adherence, compliance, and persistencePatient Prefer Adherence20126394822272068
  • LabaTLEssueBKimmanMJanSUnderstanding patient preferences in medication nonadherence: a review of stated preference dataPatient20158538539525404203
  • AttayaSBornsteinTRonquilloNStudy of warfarin patients investigating attitudes toward therapy change (SWITCH Survey)Am J Therap201219643243522198071
  • ElewaHFDeRemerCEKellerKGujralJJoshuaTVPatients satisfaction with warfarin and willingness to switch to dabigatran: a patient surveyJ Thromb Thrombolysis201438111512023918529
  • OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
  • CanoSJLampingDLBamberLSmithSThe Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patientsHealth Qual Life Outcomes20121012023013426
  • WangYKongMCLeeLHNgHJKoYKnowledge, satisfaction, and concerns regarding warfarin therapy and their association with warfarin adherence and anticoagulation controlThromb Res2014133455055424448058
  • HanonOChaussadeEGuerangerPGrusonEBonanSGayAPatient-reported treatment satisfaction with rivaroxaban for stroke prevention in atrial fibrillation. A French observational study, the SAFARI StudyPLoS One20161112e016621827935987
  • AlexanderJHLopesRDThomasLApixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trialEur Heart J201435422423224144788
  • GasparovaIKubatkaPOpatrilovaRPerspectives and challenges of antioxidant therapy for atrial fibrillationNaunyn Schmiedebergs Arch Pharmacol20173901114